Healthcare / Medical Care FacilitiesSaudi
$5.23
-0.07 (-1.32%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 34% · confianza 18%
FCF escenarios
weak_data · normalized FCF $-8.7M · quality 43.7/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
66/100
B
Piotroski
7/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
16/100
SEC 0%
Sin guardar todavía.
Market Cap
$373M
P/E
19.4x
↓EV/EBITDA
11.9x
↓ROE
21.5%
↑Gross Margin
43.5%
↓Debt/Equity
0.07
↓TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2022–2025 · 3 años de histórico normalizado
Revenue CAGR
+27.7%
FCF CAGR
—
FCF margin
-14.1%
FCF / Net income
-0.90x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $121.8M · net income $19.0M · FCF $-17.1M
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $121.8M | $121.8M | $75.5M | $74.3M | $58.6M |
| Net Income | $19.0M | $19.0M | $6.1M | $18.6M | $10.3M |
| EBITDA | $30.8M | $30.8M | $14.0M | $20.8M | $11.6M |
| EPS | 0.27 | 0.27 | 0.09 | 0.78 | 0.43 |
| Gross Margin | 43.5% | 43.5% | 41.1% | 54.7% | 48.7% |
| Operating Margin | 18.1% | 18.1% | 10.0% | 27.1% | 19.5% |
| Net Margin | 15.6% | 15.6% | 8.0% | 25.0% | 17.6% |
| Balance Sheet | |||||
| Debt/Equity | 0.07 | 0.07 | 0.15 | 0.07 | 0.09 |
| Current Ratio | 1.51 | 1.51 | — | — | — |
| Cash Flow | |||||
| Free Cash Flow | $-17.1M | $-17.1M | $-8.7M | $13.6M | $5.1M |
| Returns | |||||
| ROE | 21.5% | 21.5% | 7.9% | 47.4% | 33.3% |
| Valuation | |||||
| P/E | 19.37 | 19.37 | 59.26 | — | — |
| EV/EBITDA | 11.90 | 11.90 | 8.53 | — | — |
| P/B | 4.22 | 4.22 | 1.60 | — | — |
| Growth & Yield | |||||
| Revenue Growth | 61.4% | 61.4% | 1.6% | 26.9% | — |
| EPS Growth | 200.0% | 200.0% | -88.5% | 80.3% | — |
| Dividend Yield | 4.6% | 4.6% | — | — | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
3Y implied EPS CAGR
19.8%
EPS terminal req.
$0.46
Spread vs growth
180.2%
5Y implied EPS CAGR
15.8%
EPS terminal req.
$0.56
Spread vs growth
184.2%
10Y implied EPS CAGR
12.8%
EPS terminal req.
$0.90
Spread vs growth
187.2%
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
-5.2%
Start / end P/E
64.4x → 19.4x
EPS bridge
0.09 → 0.27
Residual
-139.8%
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.